BR0108001A - Moléculas ativadoras de apc com ligação para cd-40 - Google Patents
Moléculas ativadoras de apc com ligação para cd-40Info
- Publication number
- BR0108001A BR0108001A BR0108001-6A BR0108001A BR0108001A BR 0108001 A BR0108001 A BR 0108001A BR 0108001 A BR0108001 A BR 0108001A BR 0108001 A BR0108001 A BR 0108001A
- Authority
- BR
- Brazil
- Prior art keywords
- molecules
- monoclonal antibodies
- cells
- present
- professional
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
Abstract
"MOLéCULAS ATIVADORAS DE APC COM LIGAçãO PARA CD-40". A presente invenção refere-se a moléculas agonistas anti-CD40, incluindo anticorpos monocionais, que podem se ligar e estimular células que apresentam antígeno humano profissional e não-profissional ("APCs"), aumentar o efeito estimulatório de células positivas CD40L em CD40 e ou induzir a maturação fenotípica de células dendríticas derivadas de monócitos. São fornecidos diversos anticorpos monocionais e as linhagens celulares produtoras dos mesmos foram depositadas na American Type Culture Collection.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17893400P | 2000-02-01 | 2000-02-01 | |
PCT/US2001/003378 WO2001056603A1 (en) | 2000-02-01 | 2001-02-01 | Cd40-binding apc-activating molecules |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0108001A true BR0108001A (pt) | 2004-01-06 |
Family
ID=22654507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0108001-6A BR0108001A (pt) | 2000-02-01 | 2001-02-01 | Moléculas ativadoras de apc com ligação para cd-40 |
Country Status (9)
Country | Link |
---|---|
US (3) | US7172759B2 (pt) |
EP (2) | EP1253942A4 (pt) |
JP (1) | JP2003524644A (pt) |
CN (2) | CN100490895C (pt) |
AU (2) | AU3662101A (pt) |
BR (1) | BR0108001A (pt) |
CA (1) | CA2398998C (pt) |
MX (1) | MXPA02007473A (pt) |
WO (1) | WO2001056603A1 (pt) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6407218B1 (en) * | 1997-11-10 | 2002-06-18 | Cytimmune Sciences, Inc. | Method and compositions for enhancing immune response and for the production of in vitro mabs |
CA2223225A1 (en) * | 1997-11-28 | 1999-05-28 | Canadian Red Cross Society | Method for inhibiting in vivo immune response |
US20110041190A1 (en) * | 2002-10-31 | 2011-02-17 | Tykocinski Mark L | Novel chimeric proteins |
AU3662101A (en) * | 2000-02-01 | 2001-08-14 | Tanox Inc | Cd40-binding apc-activating molecules |
US7063845B2 (en) | 2000-04-28 | 2006-06-20 | Gemini Science, Inc. | Human anti-CD40 antibodies |
ATE374214T1 (de) | 2001-04-27 | 2007-10-15 | Kirin Brewery | Monoklonaler anti-cd-40-antikörper |
JP4360906B2 (ja) * | 2001-09-14 | 2009-11-11 | サイトス バイオテクノロジー アーゲー | ウィルス様粒子によって誘導される免疫応答を高めるための、抗原提示細胞のインビボでの活性化 |
DK1450856T3 (da) | 2001-09-14 | 2010-05-31 | Cytos Biotechnology Ag | Pakning af immunstimulatorisk CpG i virus-lignende partilker, fremgangsmåde og anvendelse |
AR039067A1 (es) * | 2001-11-09 | 2005-02-09 | Pfizer Prod Inc | Anticuerpos para cd40 |
US7537767B2 (en) | 2003-03-26 | 2009-05-26 | Cytis Biotechnology Ag | Melan-A- carrier conjugates |
CN100560719C (zh) | 2003-03-26 | 2009-11-18 | 赛托斯生物技术公司 | Melan-a肽类似物-病毒样颗粒偶联物 |
CN1925843A (zh) * | 2003-12-02 | 2007-03-07 | 细胞免疫科学公司 | 生产单克隆抗体的方法和组合物 |
US20050136055A1 (en) | 2003-12-22 | 2005-06-23 | Pfizer Inc | CD40 antibody formulation and methods |
US20070184068A1 (en) | 2005-12-14 | 2007-08-09 | Cytos Biotechnology Ag | Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
CN104357469B (zh) | 2006-05-03 | 2018-10-26 | 科罗拉多州立大学董事会 | Cd40激动剂抗体/1型干扰素协同佐剂组合、包含前述的结合物及其用途 |
NZ573622A (en) | 2006-06-12 | 2011-12-22 | Cytos Biotechnology Ag | Processes for packaging oligonucleotides into virus-like particles of rna bacteriophages |
US20090074711A1 (en) * | 2006-09-07 | 2009-03-19 | University Of Southhampton | Human therapies using chimeric agonistic anti-human cd40 antibody |
US7960145B2 (en) * | 2007-11-08 | 2011-06-14 | Cytimmune Sciences, Inc. | Compositions and methods for generating antibodies |
CN103153332A (zh) | 2010-09-28 | 2013-06-12 | 卡尔医疗有限公司 | 用于治疗血液恶性肿瘤的组合物和方法 |
CA3122934A1 (en) * | 2011-03-11 | 2012-09-20 | Beth Israel Deaconess Medical Center, Inc. | Fusion protein comprising a fragment of cd40 and method of producing same |
CN103635488B (zh) | 2011-04-29 | 2016-12-14 | 埃派斯进有限公司 | 抗-cd40抗体及其使用方法 |
CN104918957B (zh) | 2012-10-30 | 2018-11-16 | 埃派斯进有限公司 | 抗-cd40抗体及其使用方法 |
CN103793594A (zh) * | 2013-12-30 | 2014-05-14 | 上海交通大学医学院附属瑞金医院 | 一种构建肠道-胰岛调控轴相关功能评估模型的方法与应用 |
WO2016033690A1 (en) * | 2014-09-04 | 2016-03-10 | Stemcell Technologies Inc. | Soluble antibody complexes for t cell or nk cell activation and expansion |
CN113699116A (zh) | 2014-12-10 | 2021-11-26 | 明尼苏达大学董事会 | 用于治疗疾病的遗传修饰的细胞、组织和器官 |
JP6401297B2 (ja) * | 2014-12-25 | 2018-10-10 | 株式会社日立製作所 | インスリン分泌能分析装置、当該装置を備えるインスリン分泌能分析システム及びインスリン分泌能分析方法 |
MA41459A (fr) | 2015-02-03 | 2017-12-12 | Als Therapy Development Inst | Anticorps anti-cd40l et méthodes pour traiter des maladies ou des troubles liés aux cd40l |
ES2900757T3 (es) * | 2015-02-10 | 2022-03-18 | Ohio State Innovation Foundation | Plataformas de células B activadas por clamidia y procedimientos de las mismas |
WO2016166568A1 (en) | 2015-04-16 | 2016-10-20 | Juno Therapeutics Gmbh | Methods, kits and apparatus for expanding a population of cells |
US10786547B2 (en) | 2015-07-16 | 2020-09-29 | Biokine Therapeutics Ltd. | Compositions, articles of manufacture and methods for treating cancer |
BR112018004296B1 (pt) | 2015-09-04 | 2020-05-05 | Primatope Therapeutics Inc | anticorpos anti-cd40 humanizados e usos dos mesmos |
EP3356532B1 (en) | 2015-09-30 | 2022-01-19 | Janssen Biotech, Inc. | Agonistic antibodies specifically binding human cd40 and methods of use |
MA45489A (fr) | 2015-10-22 | 2018-08-29 | Juno Therapeutics Gmbh | Procédés de culture de cellules, kits et appareil associés |
MA45488A (fr) | 2015-10-22 | 2018-08-29 | Juno Therapeutics Gmbh | Procédés, kits et appareil de culture de cellules |
EP3370768B9 (en) | 2015-11-03 | 2022-03-16 | Janssen Biotech, Inc. | Antibodies specifically binding pd-1 and their uses |
CN108367058A (zh) | 2015-11-10 | 2018-08-03 | 俄亥俄州创新基金会 | 与加快的体液亲和力相关的方法和组合物 |
EP3426271A4 (en) | 2016-03-10 | 2019-10-16 | Cold Genesys, Inc. | METHODS OF TREATING SOLID OR LYMPHATIC TUMORS BY POLYTHERAPY |
AU2017252233A1 (en) * | 2016-04-22 | 2018-11-15 | Alligator Bioscience Ab | Novel bispecific polypeptides against CD137 |
PT3464361T (pt) | 2016-05-27 | 2021-12-27 | Abbvie Biotherapeutics Inc | Anticorpos anti-cd40 e suas utilizações |
JP2019519223A (ja) | 2016-05-27 | 2019-07-11 | アッヴィ・バイオセラピューティクス・インコーポレイテッド | 免疫調節タンパク質及び腫瘍抗原に結合する二重特異性結合タンパク質 |
US11091557B2 (en) | 2016-07-14 | 2021-08-17 | Genmab A/S | Methods of producing multispecific antibodies against CD40 and CD137 |
CN109863170A (zh) | 2016-08-12 | 2019-06-07 | 詹森生物科技公司 | 具有增强的激动作用和效应子功能的工程化抗体及其他含Fc结构域分子 |
SG11201900744SA (en) | 2016-08-12 | 2019-02-27 | Janssen Biotech Inc | Fc engineered anti-tnfr superfamily member antibodies having enhanced agonistic activity and methods of using them |
BR112019005895A2 (pt) | 2016-09-23 | 2019-06-11 | Merus N.V. | moléculas de ligação que modulam uma atividade biológica expressa por uma célula |
CN110382541A (zh) * | 2017-03-29 | 2019-10-25 | 葛莱高托普有限公司 | 人源化抗cd40抗体 |
AU2018260380A1 (en) | 2017-04-27 | 2019-11-07 | Juno Therapeutics Gmbh | Oligomeric particle reagents and methods of use thereof |
CN110662768B (zh) | 2017-05-24 | 2024-01-30 | Als治疗发展学会 | 治疗性抗cd40配体抗体 |
SG11202000503QA (en) | 2017-07-20 | 2020-02-27 | Aptevo Res & Development Llc | Antigen binding proteins binding to 5t4 and 4-1bb and related compositions and methods |
WO2020089343A1 (en) | 2018-10-31 | 2020-05-07 | Juno Therapeutics Gmbh | Methods for selection and stimulation of cells and apparatus for same |
KR20210100624A (ko) | 2018-11-06 | 2021-08-17 | 주노 쎄러퓨티크스 인코퍼레이티드 | 유전적으로 조작된 t 세포를 제조하는 방법 |
CN111454363B (zh) * | 2019-03-04 | 2021-03-02 | 北京天广实生物技术股份有限公司 | Cd40抗体及其用途 |
CA3159380A1 (en) | 2019-10-30 | 2021-05-06 | Juno Therapeutics Gmbh | Cell selection and/or stimulation devices and methods of use |
US11926672B2 (en) | 2019-12-20 | 2024-03-12 | Amgen Inc. | Mesothelin-targeted CD40 agonistic multispecific antibody constructs for the treatment of solid tumors |
CN111235208B (zh) * | 2020-02-28 | 2022-10-28 | 江苏大学 | 一种离子液体对糖代谢影响的评估方法 |
US20230181641A1 (en) | 2020-05-13 | 2023-06-15 | Juno Therapeutics, Inc. | Process for producing donor-batched cells expressing a recombinant receptor |
WO2022036495A1 (en) | 2020-08-17 | 2022-02-24 | Utc Therapeutics Inc. | Lymphocytes-antigen presenting cells co-stimulators and uses thereof |
WO2022234009A2 (en) | 2021-05-06 | 2022-11-10 | Juno Therapeutics Gmbh | Methods for stimulating and transducing t cells |
WO2023213969A1 (en) | 2022-05-05 | 2023-11-09 | Juno Therapeutics Gmbh | Viral-binding protein and related reagents, articles, and methods of use |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US6106835A (en) * | 1991-04-19 | 2000-08-22 | Tanox, Inc. | Modified binding molecules specific for T or B lymphocytes and their use as in vivo immune modulators |
US5637481A (en) * | 1993-02-01 | 1997-06-10 | Bristol-Myers Squibb Company | Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
EP1997894B1 (en) * | 1992-02-06 | 2011-03-30 | Novartis Vaccines and Diagnostics, Inc. | Biosynthetic binding protein for cancer marker |
EP0724456B1 (en) | 1993-10-01 | 2003-12-10 | Immunex Corporation | Antibodies to cd40 |
EP0751781B1 (en) | 1993-12-23 | 2004-05-26 | Immunex Corporation | Use of monoclonal antibodies or soluble oligomeric ligands in the manufacture of a medicament for the prevention or treatment of neoplastic disorders |
US5463564A (en) | 1994-09-16 | 1995-10-31 | 3-Dimensional Pharmaceuticals, Inc. | System and method of automatically generating chemical compounds with desired properties |
US5504004A (en) | 1994-12-20 | 1996-04-02 | Michigan Biotechnology Institute | Process for making succinic acid, microorganisms for use in the process and methods of obtaining the microorganisms |
AU3255397A (en) | 1996-07-05 | 1998-02-02 | Novo Nordisk A/S | Method for the production of precursors of insulin, precursors of insulin analogues, and insulin like peptides |
DE29611914U1 (de) | 1996-07-09 | 1997-11-06 | Bosch Gmbh Robert | Zündspule für eine Brennkraftmaschine |
CA2259140C (en) * | 1996-07-10 | 2008-09-30 | Immunex Corporation | Method of activating dendritic cells |
WO1999061057A2 (en) * | 1998-05-23 | 1999-12-02 | Tanox, Inc. | Molecules targeting cd40 and tumor cells |
ES2330017T3 (es) * | 1998-05-23 | 2009-12-03 | Leiden University Medical Center | Ligandos de cd40 y peptidos de ctl para tratar tumores. |
US6946129B1 (en) * | 1999-06-08 | 2005-09-20 | Seattle Genetics, Inc. | Recombinant anti-CD40 antibody and uses thereof |
AU3662101A (en) * | 2000-02-01 | 2001-08-14 | Tanox Inc | Cd40-binding apc-activating molecules |
CN1450912A (zh) | 2000-04-19 | 2003-10-22 | 泰诺士公司 | 用于治疗牛皮癣和其它炎性皮肤病的cd40拮抗剂 |
JP4483043B2 (ja) * | 2000-07-19 | 2010-06-16 | ヤマハ株式会社 | 楽曲データ提供装置、方法、及び記録媒体 |
-
2001
- 2001-02-01 AU AU3662101A patent/AU3662101A/xx active Pending
- 2001-02-01 EP EP01908789A patent/EP1253942A4/en not_active Ceased
- 2001-02-01 WO PCT/US2001/003378 patent/WO2001056603A1/en active Application Filing
- 2001-02-01 EP EP08157131A patent/EP1975182A1/en not_active Withdrawn
- 2001-02-01 AU AU2001236621A patent/AU2001236621B2/en not_active Ceased
- 2001-02-01 CN CNB018072453A patent/CN100490895C/zh not_active Expired - Fee Related
- 2001-02-01 MX MXPA02007473A patent/MXPA02007473A/es unknown
- 2001-02-01 JP JP2001556502A patent/JP2003524644A/ja active Pending
- 2001-02-01 CA CA2398998A patent/CA2398998C/en not_active Expired - Lifetime
- 2001-02-01 US US09/773,866 patent/US7172759B2/en not_active Expired - Lifetime
- 2001-02-01 BR BR0108001-6A patent/BR0108001A/pt not_active IP Right Cessation
- 2001-04-26 CN CNA018117716A patent/CN1942767A/zh active Pending
-
2006
- 2006-12-20 US US11/613,409 patent/US7547438B2/en not_active Expired - Fee Related
-
2009
- 2009-04-08 US US12/420,481 patent/US7820807B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20010026932A1 (en) | 2001-10-04 |
CA2398998C (en) | 2014-04-22 |
CN1443077A (zh) | 2003-09-17 |
CN100490895C (zh) | 2009-05-27 |
EP1253942A4 (en) | 2004-06-16 |
EP1253942A1 (en) | 2002-11-06 |
CN1942767A (zh) | 2007-04-04 |
AU2001236621B2 (en) | 2006-06-15 |
CA2398998A1 (en) | 2001-08-09 |
JP2003524644A (ja) | 2003-08-19 |
WO2001056603A1 (en) | 2001-08-09 |
US20070098720A1 (en) | 2007-05-03 |
US7172759B2 (en) | 2007-02-06 |
AU3662101A (en) | 2001-08-14 |
US20090311268A1 (en) | 2009-12-17 |
EP1975182A1 (en) | 2008-10-01 |
MXPA02007473A (es) | 2003-09-22 |
US7820807B2 (en) | 2010-10-26 |
US7547438B2 (en) | 2009-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0108001A (pt) | Moléculas ativadoras de apc com ligação para cd-40 | |
DE69709632T2 (de) | Humanisierte monoklonale anti-cd40 antikörper und fragmente zur hemmung der b-zellaktivierung | |
FR12C0004I2 (fr) | Anticorps contre l'antigene ctla-4 humain et utilisation | |
PT1157042E (pt) | Produção de anticorpos tetravalentes | |
AU2001296547A1 (en) | Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies | |
BG104778A (en) | Antibodies against human cd40 | |
NO20013641D0 (no) | BAFF, relaterte blokkeringsmidler samt anvendelse derav ved stimulering og inhibering av B-celler og immunoglobuliner iimmunresponser | |
ZA975851B (en) | Hepatocyte grown factor receptor agonists and uses thereof | |
TR200002731T2 (tr) | Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar | |
BR0012196A (pt) | Método de tratamento de um tumor em mamìferos através do uso de conjugados de maitansinóide e anticorpo receptor anti-erbb e artigo industrializado | |
GR3036951T3 (en) | Cells with multiple altered epitopes on a surface antigen for use in transplantation | |
EA200701804A1 (ru) | Мутации рецептора эпидермального фактора роста | |
DK0765343T3 (da) | Monoklonale antistoffer imod CD44v6 | |
ATE179799T1 (de) | Vorrichtung zur analyse von haptenen und ihre verwendung | |
SE8700467D0 (sv) | Cross-protective human monoclonal antibody compositions | |
MXPA02010147A (es) | Antagonistas cd40 para uso en el tratamiento de psoriasis y otras condiciones inflamatorias de la piel. | |
WO2001057219A3 (en) | Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods | |
SI1456238T1 (sl) | Proizvodnja f(ab)2 fragmentov v sesalskih celicah | |
ATE317021T1 (de) | Antisense modulierung von lfa-3 | |
ATE298244T1 (de) | Monoklonaler antikörper mit selektiver bindung an vgf und verwendung zur behandlung von vgf- erkrankungen | |
DE60021409D1 (de) | Neurokinin b vorläufer aus menschlicher plazenta | |
RU98104739A (ru) | Штамм культивируемых клеток мышиной гибридомы, используемый для получения моноклональных антител к ядрышковому антигену, ассоциированному с клеточной пролиферацией | |
UA85163C2 (en) | Criptoblocking antibodies and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7O E 8O ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2016 DE 25/08/2009 |